Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

Antonio Francesco Ciccaglione; Roberta Tavani; Laurino Grossi; Luigina Cellini; Lamberto Manzoli; Leonardo Marzio

doi:10.1111/hel.12296

Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

Helicobacter ◽

10.1111/hel.12296 ◽

2016 ◽

Vol 21 (5) ◽

pp. 375-381 ◽

Cited By ~ 17

Author(s):

Antonio Francesco Ciccaglione ◽

Roberta Tavani ◽

Laurino Grossi ◽

Luigina Cellini ◽

Lamberto Manzoli ◽

...

Keyword(s):

Triple Therapy ◽

Line Treatment ◽

Pilot Studies ◽

Quadruple Therapy ◽

Third Line ◽

Third Line Treatment

Download Full-text

P.15.2 RIFABUTIN CONTAINING TRIPLE THERAPY VS. RIFABUTIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR THIRD-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION

Digestive and Liver Disease ◽

10.1016/s1590-8658(14)60329-7 ◽

2014 ◽

Vol 46 ◽

pp. S111

Author(s):

R. Tavani ◽

A.F. Ciccaglione ◽

L. Cellini ◽

L. Grossi ◽

A.M. Di Tullio ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Line Treatment ◽

Quadruple Therapy ◽

Third Line ◽

H Pylori ◽

Third Line Treatment

Download Full-text

IDDF2018-ABS-0076 Optimised 14-day levofloxacin sequential versus 10-day bismuth quadruple therapy containing high dose esomeprazole in the second-line and third-line treatment of helicobacter pylori – a multicenter randomised trial

10.1136/gutjnl-2018-iddfbestabstracts.14 ◽

2018 ◽

Author(s):

Jyh-Ming Liou ◽

Chieh-Chang Chen ◽

Po-Yueh Chen ◽

Yu-Jen Fang ◽

Jaw-Town Lin ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomised Trial ◽

High Dose ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Third Line ◽

Third Line Treatment

Download Full-text

M1093 Levofloxacin- and Amoxcillin-Based Quadruple Therapy for the Third-Line Treatment of Helicobacter pylori Infection

Gastroenterology ◽

10.1016/s0016-5085(08)61569-3 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-336

Author(s):

Ping-I Hsu ◽

Deng-Chyang Wu

Keyword(s):

Helicobacter Pylori ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Quadruple Therapy ◽

The Third ◽

Third Line ◽

Third Line Treatment

Download Full-text

IDDF2019-ABS-0126 Levofloxacin sequential therapy versus bismuth quadruple therapy in the second-line and third-line treatment of helicobacter pylori -a multicenter randomized trial

10.1136/gutjnl-2019-iddfabstracts.159 ◽

2019 ◽

Author(s):

Jyh-Ming Liou ◽

Po-Yueh Chen ◽

Chieh-Chang Chen ◽

Yu-Jen Fang ◽

Ming-Jong Bair ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Sequential Therapy ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Multicenter Randomized Trial ◽

Third Line ◽

Third Line Treatment

Download Full-text

Su1377 LEVOFLOXACIN SEQUENTIAL THERAPY VERSUS BISMUTH QUADRUPLE THERAPY IN THE SECOND-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION- A MULTICENTER RANDOMIZED TRIAL

Gastroenterology ◽

10.1016/s0016-5085(20)32131-4 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-570

Author(s):

Jyh-Ming Liou ◽

Chieh-Chang Chen ◽

Yu-Jen Fang ◽

Po-Yueh Chen ◽

Jaw-Town Lin ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Trial ◽

Sequential Therapy ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Multicenter Randomized Trial ◽

Third Line ◽

Third Line Treatment

Download Full-text

Faculty Opinions recommendation of Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962393.793466337 ◽

2012 ◽

Author(s):

Ian Beales

Keyword(s):

Clinical Trial ◽

Helicobacter Pylori ◽

Sequential Therapy ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

Genotypic Resistance ◽

Multicentre Clinical Trial ◽

The Third ◽

Third Line ◽

Third Line Treatment

Download Full-text

Weekly Paclitaxel Plus Bevacizumab versus Docetaxel As Second- or Third-Line Treatment in Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Results of the IFCT-1103 ULTIMATE Study

SSRN Electronic Journal ◽

10.2139/ssrn.3410910 ◽

2019 ◽

Author(s):

Alexis Cortot ◽

Clarisse Audigier-Valette ◽

Olivier Molinier ◽

Sylvestre Le Moulec ◽

Fabrice Barlesi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Weekly Paclitaxel ◽

Line Treatment ◽

Small Cell Lung ◽

Third Line ◽

Third Line Treatment

Download Full-text

Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study

The Lancet Oncology ◽

10.1016/s1470-2045(17)30759-3 ◽

2017 ◽

Vol 18 ◽

pp. S3 ◽

Cited By ~ 11

Author(s):

Baohui Han ◽

Kai Li ◽

Qiming Wang ◽

Yizhuo Zhao ◽

Li Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Third Line ◽

Third Line Treatment

Download Full-text

PCN52 Cost-Effectiveness Analysis of the Third-LINE Treatment of Regorafenib for Metastatic or Unresectable Gastrointestinal Stromal Tumors in China

Value in Health ◽

10.1016/j.jval.2021.04.144 ◽

2021 ◽

Vol 24 ◽

pp. S28

Author(s):

Y. Wang ◽

M. Rui ◽

Y.D. Cao ◽

Z. Fei ◽

A.X. Ma ◽

...

Keyword(s):

Cost Effectiveness ◽

Gastrointestinal Stromal Tumors ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

Stromal Tumors ◽

The Third ◽

Effectiveness Analysis ◽

Third Line ◽

Third Line Treatment

Download Full-text

Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report

International Journal of Surgery Case Reports ◽

10.1016/j.ijscr.2021.106161 ◽

2021 ◽

pp. 106161

Author(s):

Toshiaki Komo ◽

Takahisa Suzuki ◽

Hirofumi Tazawa ◽

Haruki Sada ◽

Hiroshi Morimoto ◽

...

Keyword(s):

Gastric Cancer ◽

Case Report ◽

Advanced Gastric Cancer ◽

Peritoneal Dissemination ◽

Complete Response ◽

Line Treatment ◽

Clinical Complete Response ◽

Third Line ◽

Third Line Treatment

Download Full-text